SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan
International Journal of Environmental Research & Public Health [Electronic Resource]
; 18(7):05, 2021.
Article
in English
| MEDLINE | ID: covidwho-1210022
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2160 healthcare workers in hospitals and clinics that are not designated to treat COVID-19 patients in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020 (during and after the second wave of the pandemic in Japan), which is relatively higher than that in the general population in Japan (0.03-0.91%). Because of the higher risk of COVID-19 infection, healthcare workers should be the top priority for further social support and vaccination against SARS-CoV-2.
Full text:
Available
Collection:
Databases of international organizations
Database:
MEDLINE
Type of study:
Observational study
Language:
English
Journal:
International Journal of Environmental Research & Public Health [Electronic Resource]
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS